Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -291.57%-7.41M | 103.51%1.09M | 59.46%-15.77M | -17.21%13.5M | 94.97%-503K | 151.27%3.87M | 31.58%-31.05M | -1.01%-38.9M | 669.28%16.3M | -107.91%-9.99M |
Net income from continuing operations | 72.15%3.96M | -355.93%-13.44M | 93.45%-216K | -522.76%-17.02M | 392.08%1.49M | -45.44%2.3M | -98.90%5.25M | -105.84%-3.3M | -98.95%4.03M | -98.49%303K |
Operating gains losses | -672.67%-3.73M | 3,844.19%22.54M | -69.32%547K | 11,474.75%22.98M | -141.51%-501K | 85.75%-483K | 99.90%-602K | 102.58%1.78M | 99.96%-202K | 106.01%1.21M |
Depreciation and amortization | -8.92%2.9M | -13.99%12.53M | -29.31%2.87M | -0.63%3.32M | -7.56%3.17M | -15.18%3.19M | 11.14%14.57M | 9.48%4.05M | 9.59%3.34M | 8.63%3.43M |
Change In working capital | -801.80%-10.52M | 57.63%-21.97M | 53.88%-19.44M | -54.68%4.17M | 65.10%-5.54M | 61.71%-1.17M | -236.74%-51.87M | -36.40%-42.16M | -88.18%9.21M | -189.94%-15.87M |
-Change in receivables | -210.13%-1.44M | 90.88%-1.01M | 102.46%165K | 343.16%3.32M | -5.65%-4.04M | -156.72%-464K | -46.09%-11.08M | -602.83%-6.71M | 49.03%-1.37M | -8.00%-3.82M |
-Change in payables and accrued expense | -254.88%-7.31M | 53.82%-14.09M | 47.59%-19.13M | -45.47%7.39M | 96.67%-291K | -276.61%-2.06M | -180.86%-30.51M | 14.42%-36.51M | -84.61%13.56M | -1,030.70%-8.73M |
-Change in other current assets | -229.65%-1.76M | 33.11%-6.87M | -144.59%-474K | -119.45%-6.54M | 63.51%-1.21M | 127.02%1.36M | -232.01%-10.27M | -91.63%1.06M | 60.12%-2.98M | -15.58%-3.32M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -291.57%-7.41M | 103.51%1.09M | 59.46%-15.77M | -17.21%13.5M | 94.97%-503K | 151.27%3.87M | 31.58%-31.05M | -1.01%-38.9M | 669.28%16.3M | -107.91%-9.99M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -243.68%-16.63M | -254.18%-41.34M | -139.70%-14.44M | -2,915.28%-23.88M | -194.51%-14.59M | 147.80%11.57M | -91.28%26.81M | -76.15%36.38M | -100.65%-792K | -45.15%15.44M |
Net investment purchase and sale | -65.44%4.94M | -63.71%10.65M | -71.99%12.25M | -481.45%-10.63M | -126.91%-5.27M | 138.88%14.3M | 128.65%29.34M | 201.03%43.74M | 104.14%2.79M | -21.16%19.58M |
Net other investing changes | 62.20%4.87M | 208.62%5.95M | -61.50%283K | 4,964.15%2.68M | 99.58%-27K | 1,212.23%3.01M | -112.40%-5.47M | 544.74%735K | -99.55%53K | -278.25%-6.49M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -243.68%-16.63M | -254.18%-41.34M | -139.70%-14.44M | -2,915.28%-23.88M | -194.51%-14.59M | 147.80%11.57M | -91.28%26.81M | -76.15%36.38M | -100.65%-792K | -45.15%15.44M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 1,171.43%15.6M | 101.19%1.66M | 188.98%1.57M | 224.28%2.45M | 98.05%-898K | 98.37%-1.46M | -23.71%-139.02M | 95.69%-1.76M | 93.79%-1.97M | -4,214.39%-46.16M |
Net issuance payments of debt | 1,997.32%16.28M | 101.93%2.66M | 284.67%1.57M | 242.66%2.81M | 98.13%-857K | 99.04%-858K | -23.99%-137.66M | 97.92%-848K | 93.63%-1.97M | -4,173.74%-45.73M |
Net common stock issuance | -15.67%-679K | 11.67%-802K | --0 | ---215K | --0 | ---587K | ---908K | ---908K | --0 | --0 |
Net other financing activities | ---- | 56.26%-199K | --0 | ---147K | 90.57%-41K | 31.25%-11K | 66.42%-455K | -300.00%-4K | --0 | ---435K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 1,171.43%15.6M | 101.19%1.66M | 188.98%1.57M | 224.28%2.45M | 98.05%-898K | 98.37%-1.46M | -23.71%-139.02M | 95.69%-1.76M | 93.79%-1.97M | -4,214.39%-46.16M |
Net cash flow | ||||||||||
Beginning cash position | -48.81%40.48M | -64.44%79.07M | -17.07%69.12M | 10.39%77.06M | -15.81%93.05M | -64.44%79.07M | 205.67%222.33M | -44.13%83.35M | 20.99%69.81M | 212.01%110.53M |
Current changes in cash | -160.34%-8.44M | 73.06%-38.59M | -569.14%-28.65M | -158.63%-7.94M | 60.73%-15.99M | 112.51%13.99M | -195.77%-143.26M | -105.85%-4.28M | -85.20%13.54M | -282.84%-40.72M |
End cash Position | -65.57%32.04M | -48.81%40.48M | -48.81%40.48M | -17.07%69.12M | 10.39%77.06M | -15.81%93.05M | -64.44%79.07M | -64.44%79.07M | -44.13%83.35M | 20.99%69.81M |
Free cash flow | -291.57%-7.41M | 103.51%1.09M | 59.46%-15.77M | -17.21%13.5M | 94.97%-503K | 151.27%3.87M | 31.58%-31.05M | -1.01%-38.9M | 669.28%16.3M | -107.91%-9.99M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |